ZIM
AGIO icon

Zacks Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Zacks Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,901
Closed -$275K – 555
2015
Q3 		$275K Buy
+3,901
New +$381K 0.01% 519

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zacks Investment Management's AGIO Position: Q4 2015 in Review

Zacks Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2015, closing a stake of 3,901 shares — an estimated $275K sold.

Zacks Investment Management first reported a position in AGIO in Q3 2015 and held it in 1 quarter. The position peaked at $275K in Q3 2015. 144 funds tracked by Wall St. Rank hold AGIO as of Q4 2015.

  • Zacks Investment Management reported no remaining Agios Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Zacks Investment Management sold 3,901 Agios Pharmaceuticals shares in Q4 2015, an estimated $275K.
  • Zacks Investment Management first reported a position in Agios Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Zacks Investment Management's Agios Pharmaceuticals position peaked at $275K in Q3 2015.
  • 144 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2015.

Based on Zacks Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.